| Title |
Current Applications and Future Perspectives of CRISPR-Cas9 for the Treatment of Lung Cancer
|
|---|---|
| Published in |
Biologics: Targets & Therapy, May 2021
|
| DOI | 10.2147/btt.s310312 |
| Pubmed ID | |
| Authors |
Markeshaw Tiruneh G/Medhin, Endeshaw Chekol Abebe, Tekeba Sisay, Nega Berhane, Tesfahun Bekele, Tadesse Asmamaw Dejenie |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 49 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 49 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 8 | 16% |
| Student > Postgraduate | 3 | 6% |
| Unspecified | 2 | 4% |
| Student > Ph. D. Student | 2 | 4% |
| Student > Master | 2 | 4% |
| Other | 2 | 4% |
| Unknown | 30 | 61% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 6 | 12% |
| Medicine and Dentistry | 4 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 6% |
| Unspecified | 2 | 4% |
| Economics, Econometrics and Finance | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 30 | 61% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 August 2022.
All research outputs
#16,734,944
of 25,392,582 outputs
Outputs from Biologics: Targets & Therapy
#187
of 284 outputs
Outputs of similar age
#265,349
of 453,943 outputs
Outputs of similar age from Biologics: Targets & Therapy
#8
of 12 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,943 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.